Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Retained Earnings (2016 - 2025)

STRATA Skin Sciences' Retained Earnings history spans 14 years, with the latest figure at -$254.5 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 4.46% year-over-year to -$254.5 million; the TTM value through Sep 2025 reached -$254.5 million, down 4.46%, while the annual FY2024 figure was -$248.1 million, 4.24% down from the prior year.
  • Retained Earnings for Q3 2025 was -$254.5 million at STRATA Skin Sciences, down from -$252.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$220.3 million in Q2 2021 and bottomed at -$254.5 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$233.2 million (2023), against an average of -$234.6 million.
  • The largest annual shift saw Retained Earnings fell 1.05% in 2021 before it decreased 4.94% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$221.7 million in 2021, then dropped by 2.5% to -$227.2 million in 2022, then fell by 4.77% to -$238.1 million in 2023, then fell by 4.24% to -$248.1 million in 2024, then fell by 2.55% to -$254.5 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Retained Earnings are -$254.5 million (Q3 2025), -$252.8 million (Q2 2025), and -$250.3 million (Q1 2025).